Emerging Technologies for the Next Medical Revolution
Monday, September 20, 2004, 12:00 Noon-1:30 PM
902 Senate Hart Office Building
The worldwide market for nanotechnology-derived goods is expected to reach $1 trillion by 2015, with one-third of the new technologies developed from advances in both the nano- and bio-revolutions—nanobiotechnologies. These technologies will play a key role in the next generation of medical advances. From new medical diagnostics that can detect cancer at the molecular level to the next generation of targeted pharmaceuticals, the societal and economic benefits will be staggering. These innovations are also critical to our long-term competitiveness by fueling economic expansion, creating new high-wage jobs, and driving productivity and growth.
This briefing explored the revolutionary medical possibilities, the economic opportunities from this annual $300 billion market, and the roles that the federal government, industry, finance, and research universities can play in this medical technology revolution.
ACS Committee on Corporation Associates and the U.S. Department of Commerce Technology Administration
Phillip J. Bond
Theodore O. Poehler